Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III European study of lisdexamfetamine in children and adolescents with ADHD
NL-OMON31918Phase 3Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lisdexamfetamine, sponsored by PRA Health Sciences. Started Oct 2008; status: active, not recruiting.
02
Drugs
lisdexamfetamine
Beyond the preview
Go deeper on NL-OMON31918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31918.